$SCYX
SCYNEXIS INC Stock $scyx

$scyx Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000162828016020925 Filed on November 07, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$65.00K	$64.00K	$64.00K
YoY Change	1.56%	0.0%	4.92%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.910M	$1.880M	$4.143M
YoY Change	-24.8%	-54.62%	95.33%
% of Gross Profit
Research & Development	$3.780M	$4.890M	$3.458M
YoY Change	-36.15%	41.41%	39.55%
% of Gross Profit
Depreciation & Amortization	$20.00K	$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit
Operating Expenses	$5.700M	$6.770M	$7.601M
YoY Change	-32.54%	-10.93%	65.28%
Operating Profit	-$5.631M	-$6.706M	-$7.537M
YoY Change	-32.86%	-11.03%	66.09%
Interest Expense	$2.180M	$0.00	$8.000K
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$4.522M	$8.000K
YoY Change		-56625.0%
Pretax Income	-$3.450M	-$11.23M	-$7.529M
YoY Change	-58.88%	49.16%	65.91%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$3.449M	-$11.23M	-$8.355M
YoY Change	-58.88%	34.39%	119.64%
Net Earnings / Revenue	-5306.15%	-17543.75%	-13054.69%
Basic Earnings Per Share			-$0.60
Diluted Earnings Per Share	-$1.426M	-$4.799M	-$0.60
COMMON SHARES
Basic Shares Outstanding	23.99M shares		13.90M shares
Diluted Shares Outstanding			13.90M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.60M	$52.40M	$53.80M
YoY Change	24.68%	-2.6%	58.24%
Cash & Equivalents	$35.66M	$29.81M	$53.77M
Short-Term Investments	$22.90M	$22.50M
Other Short-Term Assets	$41.00K	$70.00K	$872.0K
YoY Change	7.89%	-91.97%	-51.56%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$59.33M	$54.19M	$55.92M
YoY Change	22.48%	-3.1%	51.97%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$6.000M
YoY Change
Other Assets	$120.0K	$431.0K	$86.00K
YoY Change	-71.36%	401.16%	-18.87%
Total Long-Term Assets	$465.0K	$6.821M	$172.0K
YoY Change	-44.38%	3865.7%	-96.67%
TOTAL ASSETS
Total Short-Term Assets	$59.33M	$54.19M	$55.92M
Total Long-Term Assets	$465.0K	$6.821M	$172.0K
Total Assets	$59.79M	$61.01M	$56.10M
YoY Change	21.35%	8.77%	33.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.192M	$2.468M	$796.0K
YoY Change	254.12%	210.05%	24.38%
Accrued Expenses	$1.268M	$1.306M	$1.539M
YoY Change	-59.73%	-15.14%	-23.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$3.717M	$4.038M	$5.393M
YoY Change	-44.22%	-25.13%	68.69%
LONG-TERM LIABILITIES
Long-Term Debt	$14.25M	$14.17M	$0.00
YoY Change
Other Long-Term Liabilities	$7.000M	$9.600M	$700.0K
YoY Change	900.0%	1271.43%	-73.08%
Total Long-Term Liabilities	$14.25M	$14.17M	$700.0K
YoY Change		1923.86%	-73.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.717M	$4.038M	$5.393M
Total Long-Term Liabilities	$14.25M	$14.17M	$700.0K
Total Liabilities	$24.97M	$27.84M	$6.125M
YoY Change	240.97%	354.47%	5.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$180.1M	-$176.7M	-$141.7M
YoY Change	19.97%	24.64%	23.86%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.82M	$33.18M	$49.97M
YoY Change
Total Liabilities & Shareholders Equity	$59.79M	$61.01M	$56.10M
YoY Change	21.35%	8.77%	33.67%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	-$3.449M	-$11.23M	-$8.355M
YoY Change	-58.88%	34.39%	119.64%
Depreciation, Depletion And Amortization	$20.00K	$0.00	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$4.550M	-$6.850M	-$5.740M
YoY Change	-24.04%	19.34%	55.98%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$10.00K	-$20.00K
YoY Change	-75.0%	-50.0%	-93.55%
Acquisitions
YoY Change
Other Investing Activities	$5.620M	-$15.60M	$2.550M
YoY Change	-1618.92%	-711.76%
Cash From Investing Activities	$5.630M	-$15.61M	$2.530M
YoY Change	-1473.17%	-717.0%	-916.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.780M	14.40M	-80.00K
YoY Change	-1357.89%	-18100.0%	-80.0%
NET CHANGE
Cash From Operating Activities	-4.550M	-6.850M	-5.740M
Cash From Investing Activities	5.630M	-15.61M	2.530M
Cash From Financing Activities	4.780M	14.40M	-80.00K
Net Change In Cash	5.860M	-8.060M	-3.290M
YoY Change	-186.43%	144.98%	-25.06%
FREE CASH FLOW
Cash From Operating Activities	-$4.550M	-$6.850M	-$5.740M
Capital Expenditures	-$10.00K	-$10.00K	-$20.00K
Free Cash Flow	-$4.540M	-$6.840M	-$5.720M
YoY Change	-23.7%	19.58%	69.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	1903000	USD
CY2016Q3	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	516000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001178253
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23990603	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1999-11-04
	dei	Entity Registrant Name EntityRegistrantName	SCYNEXIS INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2015Q4	scyx	Accrued Severanceand Retention Costs Current AccruedSeveranceandRetentionCostsCurrent	2639000	USD
CY2016Q3	scyx	Accrued Severanceand Retention Costs Current AccruedSeveranceandRetentionCostsCurrent	7000	USD
CY2016Q3	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	52000	USD
	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	3388000	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	65000	USD
CY2013Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P70M
CY2015Q4	scyx	Disposal Group Including Discontinued Operations Cash Held In Escrow DisposalGroupIncludingDiscontinuedOperationsCashHeldInEscrow	500000	USD
CY2016Q3	scyx	Disposal Group Including Discontinued Operations Cash Held In Escrow DisposalGroupIncludingDiscontinuedOperationsCashHeldInEscrow	0	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-108000	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	0	USD
CY2016Q3	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2015Q4	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	108000	USD
CY2016Q3	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	262000	USD
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	12000	USD
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	0	USD
CY2015Q3	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	3553000	USD
	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	11352000	USD
CY2016Q3	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	5091000	USD
	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	16881000	USD
CY2015Q3	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	95000	USD
	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	827000	USD
CY2016Q3	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	201000	USD
	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	588000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	619000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2468000	USD
CY2015Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	776000	USD
CY2016Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	569000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3149000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53766000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	111000	USD
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1306000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192069000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	209827000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	908000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	244000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1541000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2656000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	293000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	908000	USD
CY2015Q4	us-gaap	Assets Assets	49273000	USD
CY2016Q3	us-gaap	Assets Assets	61012000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	48437000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	54191000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32243000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46985000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29809000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	21523000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17176000	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2016Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2161458	shares
CY2016Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7080921	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13905599	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23430868	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13905599	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23430868	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	14000	USD
CY2016Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	23000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	426000	USD
CY2015Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	417000	USD
CY2016Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	360000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	25000	USD
CY2016Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	25000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2016Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	635000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1018000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-193000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	855000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.53
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	42000	USD
CY2016Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2016Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2016Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	442000	USD
	us-gaap	Depreciation Depreciation	447000	USD
	us-gaap	Depreciation Depreciation	11000	USD
CY2015Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	-0.06
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	-0.37
CY2016Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-73000	USD
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.60
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.09
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2015Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2016Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4570000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4469000	USD
CY2016Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	28574000	USD
CY2016Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	7000	USD
CY2016Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	48000	USD
CY2015Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2016Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	22544000	USD
CY2016Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	28533000	USD
CY2015Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	0	USD
CY2016Q3	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	6030000	USD
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	586000	USD
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7529000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19950000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11228000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-26540000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.54
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-1.72
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.48
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-1.53
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-826000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4285000	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-431000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	939000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	2809000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-2631000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	523000	USD
CY2015Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	8000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	10000	USD
CY2016Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	48000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	115000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	67000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	7324000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	27836000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49273000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61012000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6664000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4038000	USD
CY2016Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	64000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	193000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2016Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14167000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38084000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35721000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2002000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28098000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18563000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24799000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-8355000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24235000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-11228000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26540000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4522000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4354000	USD
CY2015Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	430000	USD
CY2016Q3	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	1017000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	7601000	USD
	us-gaap	Operating Expenses OperatingExpenses	20153000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	6770000	USD
	us-gaap	Operating Expenses OperatingExpenses	22379000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7537000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19960000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6706000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22186000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	565000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	182000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	307000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	76000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	428000	USD
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	214000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	38000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1880000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6086000	USD
CY2015Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1379727	shares
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4890000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16293000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	500000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	41400000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23077000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	15000000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	106000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	21000	USD
CY2013Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1500000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	6932000	USD
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	0	USD
CY2015Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2016Q3	us-gaap	Other Assets Current OtherAssetsCurrent	70000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	419000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	431000	USD
CY2015Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	91000	USD
CY2016Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	89000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	589000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3422000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1788000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	35506000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	547000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1452000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1838000	USD
CY2015Q4	us-gaap	Prepaid Insurance PrepaidInsurance	285000	USD
CY2016Q3	us-gaap	Prepaid Insurance PrepaidInsurance	400000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	2549000	USD
CY2016Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Profit Loss ProfitLoss	-24235000	USD
	us-gaap	Profit Loss ProfitLoss	-26540000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3458000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10525000	USD
	us-gaap	Revenues Revenues	193000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4143000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9628000	USD
CY2016Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1815583	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	21000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150134000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-176674000	USD
CY2015Q3	us-gaap	Revenues Revenues	64000	USD
	us-gaap	Revenues Revenues	193000	USD
CY2016Q3	us-gaap	Revenues Revenues	64000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16594000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	41949000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	33176000	USD
CY2015Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	USD
CY2016Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	9164000	USD
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13904331	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11576498	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23425007	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17329441	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of cash on deposit with a bank, which exceeds the FDIC insurance limits, as well as accounts receivable. Ongoing credit evaluations of the bank and customers' financial condition and independent ratings are reviewed by the Company. </font></div></div>
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales. The Company classifies non-refundable upfront payments, milestone payments and royalties received under collaboration and licensing agreements as revenues within its statements of operations because the Company views such activities as being central to its business operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) fees are fixed or determinable, and (iv) collection of fees is reasonably assured. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting. An element qualifies as a separate unit of accounting when the delivered element has standalone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Non-refundable upfront license fees are recorded as deferred revenue and recognized into revenue on a straight-line basis over the estimated period of the Company’s substantive performance obligations. If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied. Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have standalone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have standalone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. In such instances, the license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company will recognize a milestone payment when earned if it is substantive and the Company has </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">no</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company’s deferred revenue includes non-refundable upfront payments received under certain licensing and collaboration arrangements that contain substantive performance obligations that the Company is providing over respective defined service or estimated relationship periods. Such non-refundable upfront payments are recognized over these defined service or estimated relationship periods.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-16-020925-index-headers.html	Edgar Link	pending
0001628280-16-020925-index.html	Edgar Link	pending
0001628280-16-020925.txt	Edgar Link	pending
0001628280-16-020925-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
q32016exhibit101.htm	Edgar Link	pending
q32016exhibit121.htm	Edgar Link	pending
q32016exhibit311.htm	Edgar Link	pending
q32016exhibit312.htm	Edgar Link	pending
q32016exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scyx-20160930.xml	Edgar Link	completed
scyx-20160930.xsd	Edgar Link	pending
scyx-20160930x10q.htm	Edgar Link	pending
scyx-20160930_cal.xml	Edgar Link	unprocessable
scyx-20160930_def.xml	Edgar Link	unprocessable
scyx-20160930_lab.xml	Edgar Link	unprocessable
scyx-20160930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCYX
SCYNEXIS INC Stock $scyx

2016 Q4 Form 10-Q Financial Statement

#000162828016020925 Filed on November 07, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX SCYNEXIS INC Stock $scyx

2016 Q4 Form 10-Q Financial Statement

#000162828016020925 Filed on November 07, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX
SCYNEXIS INC Stock $scyx